öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º»Æ½¨´º
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º217

ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£º½²Ê¦
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©¼Áѧ
Ñо¿ÁìÓò£º Ò©ÎïÖƼÁÑо¿¡¢¿¹ÐÄѪ¹Ü¼²²¡Ò©Îï¼°¿¹¸ÎÑ×Ò©ÎïÑо¿
Ñо¿ÁìÓò£º Ò©ÎïÖƼÁÑо¿¡¢¿¹ÐÄѪ¹Ü¼²²¡Ò©Îï¼°¿¹¸ÎÑ×Ò©ÎïÑо¿ [ÊÕÆð]




¿ÆÑй¤×÷ :
¿ÆÑпÎÌ⣺Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿1Ï¹ú¼Ò½ÌÓý²¿»ôÓ¢¶«½ÌÓý»ù½ðÏîÄ¿1Ï¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð2Ï¹ãÎ÷ÖصãʵÑéÊÒ¿ª·Å¿ÎÌâ1ÏÓÅÐ㲩ʿѧλÂÛÎÄÅàÓýÏîÄ¿1ÏÖ÷Òª²ÎÓë¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¿ÎÌâ4Ï¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð1Ïî¡£
¿ÆÑн±Àø£º»ñµÃ¹ãÎ÷×ÔÈ»¿Æѧ½±¶þµÈ½±1ÏÅÅÃûµÚ4£©¡¢¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹ㽱ÈýµÈ½±1ÏÅÅÃûµÚ4£©¡£×¨Àû£º²ÎÓë·¢Ã÷רÀû6¼þ¡£
¿ÆÑÐÂÛÎÄ£ºÒÑ·¢±íSCIÂÛÎÄ18ƪ£¬×ÜIF53.843£¨ÆäÖеÚÒ»×÷Õß8ƪ£¬×ÜIF30.896£¬×î¸ßIF4.652£©£¬ÒÑ·¢±íÖÐÎĺËÐÄÆÚ¿¯ÂÛÎÄ30Óàƪ£¨ÆäÖеÚÒ»×÷Õß»òͨѶ×÷ÕßÂÛÎÄ8ƪ£©¡££¨1£©½üÄêÖ÷Òª·¢±íµÄÂÛÎÄ£ºÒÑ·¢±íSCIÂÛÎÄ8ƪ£¨¾ùΪµÚÒ»×÷Õß»ò²¢ÁеÚÒ»×÷Õߣ©£»·¢±í¿ÆÑÐÖÐÎĺËÐÄÆÚ¿¯ÂÛÎÄ5ƪ£¨ÆäÖеÚÒ»×÷Õß2ƪ£¬Í¨Ñ¶×÷Õß3ƪ£©[1]?Jianchun?Huang#,?Xudong?Zhang#,?Feizhang?Qin,?Yingxin?Li,?Xiaoqun?Duan,?Jie?Jian,?Yongwen?Li,?Jian?Chen,?Renbin?Huang*.??Protective?Effects?of?Millettia?Pulchra?Flavonoids?on?Myocardial?Ischemia?In?Vitro?and?In?Vivo.?Cellular?Physiology?and?Biochemistry,?2015,?35(2):516-528.£¨SCI,?IF?4.652£¬µÚÒ»×÷Õߣ©[2]?Jianchun?Huang#,?XiaoJun?Tang#,?Xingmei?Liang,?Qingwei?Wen,?Shijun?Zhang,?Feifei?Xuan,?Jie?Jian,?Xing?Lin,?Renbin?Huang*.?The?effects?of?17-methoxyl-7-hydroxy-benzene-furanchalcone?on?the?pressure?overload-induced?progression?of?cardiac?hypertrophy?to?cardiac?failure.?PLoS?ONE,?2014,?9(3):?e91834.£¨SCI,?IF?3.234£¬µÚÒ»×÷Õߣ©[3]?Jianchun?Huang#,?Xiaojun?Tang#,?Xingmei?Liang,?Qingwei?Wen,?Shijun?Zhang,?Feifei?Xuan,?Jie?Jian,?Xing?Lin,?Renbin?Huang*.?The?Effects?of?17-Methoxyl-7-Hydroxy-?Benzene-Furanchalcone?on?Pressure?Overload-Induced?Cardiac?Remodeling?in?Rats?and?the?Endothelial?Mechanisms?Based?on?PGI2.?Cellular?Physiology?and?Biochemistry,?2015,?36,?1004-1014.?(SCI,?IF4.652£¬µÚÒ»×÷Õß)[4]?Jianchun?Huang#,?Xiaojun?Tang#,??Fangxing?Ye,?Junhui?He,?Xiaolong?Kong*.?Clinical?Therapeutic?Effects?of?Aspirin?in?Combination?with?Fufang?Danshen?Diwan,?a?Traditional?Chinese?Medicine?Formula,?on?Coronary?Heart?Disease:?A?Systematic?Review?and?Meta-Analysis.?Cellular?Physiology?and?Biochemistry,?2016,?39(5):1955-1963.£¨SCI,?IF?4.652£¬µÚÒ»×÷Õߣ©[5]?Jianchun?Huang#,?VanphucNguyen#,?XiaojunTang,?JinbinWei,?XingLin,?ZefengLai,?Vanminh?Doan,?QiuqiaoXie,?RenbinHuang*.?Protection?from?diclofenac-induced?liver?injury?by?Yulangsan?polysaccharide?in?a?mouse?model.?Journal?of?Ethnopharmacology,?2016,?193:?207¨C213.£¨SCI,?IF?3.055£¬µÚÒ»×÷Õߣ©[6]?Yizhu?Dong?#,?Jianchun?Huang#,?Xing?Lin,?Shijun?Zhang,?Yang?Jiao,?Tao?Liang,?Zhaoni?Chen,?Renbin?Huang*,?Hepatoprotective?effects?of?Yulangsan?polysaccharide?against?isoniazid?and?rifampicin-induced?liver?injury?in?mice.?Journal?of?Ethnopharmacology,?2014,?152(1):?201-206.?(SCI,?IF?2.998£¬²¢ÁеÚÒ»×÷Õß)??[7]?VanphucNguyen#,?JianchunHuang#,?VanminhDoan,?XingLin,?XiunengTang,?YuanhengHuang,?AicunTang,?XinYang,?RenbinHuang.?Hepatoprotective?effects?of?Yulangsan?polysaccharide?against?nimesulide-induced?liver?injury?in?mice.?Journal?of?Ethnopharmacology,?2015,172:273-280.£¨SCI£¬IF?3.055£¬²¢ÁеÚÒ»×÷Õߣ©[8]?Xiaojun?Tang#,?Jianchun?Huang#,??Hao?Xiong?,?Keyuan?Zhang,?Chunxia?Chen,?Xiaojie?Wei,??Xiaohui?Xu,??Qiuqiao?Xie,?Renbin?Huang*.?Anti-Tumor?Effects?of?the?Polysaccharide?Isolated?from?Tarphochlamys?Affinis?in?H22?Tumor-Bearing?Mice.??Cellular?Physiology?and?Biochemistry,2016,39(3):1040-1050.£¨SCI,?IF?4.652£¬²¢ÁеÚÒ»×÷Õߣ©?[9]?»Æ½¨´º,?Áõ´Ï»Û,?ÖÜ»¶»¶,?Ì·Àö·ï,?»Æ½¨¾²,?ÀîµäÅô*?,?»ÆÈʱò*?.?ÓñÀÉÉ¡²é¶ûͪ¶ÔÒì±ûÉöÉÏÏÙËØÖÂСÊóÐÄÊÒÖع¹µÄ±£»¤×÷ÓÃ.Ò½Ò©µ¼±¨£¬2014£¬33£¨06£©£º703-707.?£¨ÖÐÎĺËÐÄ£¬µÚÒ»×÷Õߣ©[10]?»Æ½¨´º£¬ÇäÀö¾ê£¬¶Pö­ö­£¬ÁºÐÓ÷£¬»ÆÈʱò*.?ÓñÀÉÉ¡¶¹çÞ´¼µÄÌåÍ⿹Ñõ»¯»îÐÔÑо¿.ÖйúʵÑé·½¼ÁѧÔÓÖ¾,?2014,?20(05):154-156.?£¨ÖÐÎĺËÐÄ£¬µÚÒ»×÷Õߣ©??[11]?ÌÀС¾ü,?»Æ½¨´º*,?Áºèº,?»ÆÈʱò.?ÁùÔÂÇàÔíÜÕ¶ÔÃâÒßÒÖÖÆСÊóÃâÒß¹¦ÄܵÄÓ°Ïì.?ÖйúÃâÒßѧÔÓÖ¾,?2013,?29(05):486-489+494.??£¨ÖÐÎĺËÐÄ£¬Í¨Ñ¶×÷Õߣ©[12]?ÌÀС¾ü,?»ÆÈʱò,?¬ͥæÃ,?»Æ½¨´º*.?ÁùÔÂÇà¶àÌÇÔÚÌåÍâ¶ÔS180ÈâÁöµÄÓ°Ïì¼°»úÖÆ.?ɽ¶«Ò½Ò©,?2016,?56(44):?30-32.?£¨ÖÐÎĺËÐÄ£¬Í¨Ñ¶×÷Õߣ©[13]?£Ó£È£×£Å£È£Ì£Á,?»ÆÈʱò,?ºÎÇÉÁá,?ÌÀС¾ü,?»Æ½¨´º*.?ÓñÀÉÉ¡¶àÌǶԿ¹½áºËÒ©ÓÕµ¼¸Îϸ°ûËðÉ˵ı£»¤×÷ÓÃ.?»ªÎ÷ҩѧÔÓÖ¾,?2015,?30(3):?292-294£¨ÖÐÎĺËÐÄ£¬Í¨Ñ¶×÷Õߣ©£¨2£©½±Àø£º?½±ÀøÒ»£º»ÆÈʱò£¬ÁÖÐË£¬ÕÅÊ¿¾ü£¬»Æ½¨´º£¬³ÂÕ×ÄÞ£¬ÁõêØ£¬¸´·½ÁùÔÂÇ࿹ÒÒÐ͸ÎÑ׺͸ÎÏËά»¯µÄÓ¦Óûù´¡Ñо¿£¬¹ãÎ÷¿Æѧ¼¼ÊõÌü£¬¹ãÎ÷×ÔÈ»¿Æѧ½±£¬¶þµÈ½±£¬2013Äꣻ½±Àø¶þ£º»ÆÈʱò£¬ÕÅÊ¿¾ü£¬½¯Î°ÕÜ£¬ÁÖ¾ü£¬»Æ½¨´º£¬¸´·½ÁùÔÂÇ࿹ÒÒÐ͸ÎÑ׺͸ÎÏËά»¯µÄ»ù´¡ÓëÓ¦ÓÃÑо¿£¬¹ãÎ÷ÎÀÉú¿Æ½Ì¹ÜÀíѧ»á£¬¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹ㽱£¬ÈýµÈ½±£¬2010Äꣻ½±ÀøÈý£º»ÆÈʱò£¬½¯Î°ÕÜ£¬ÁÖÐË£¬Áõ»ª¸Ö£¬¸¶Êéæ¼£¬¼ò½à£¬»Æ½¨´º£¬»ÆÖÒÊ˵È.?¹ãÎ÷Ãñ×åÌØÉ«Ò©ÓñÀÉÉ¡µÄÓ¦Óûù´¡Ñо¿£¬Öйúҩѧ»á¿Æѧ¼¼Êõ½±£¬ÈýµÈ½±£¬2010Äê¡££¨3£©¿ÆÑÐÏîÄ¿£ºÏîÄ¿Ò»£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðµØÇø¿Æѧ»ù½ðÏîÄ¿£¬»ùÓÚeNOS-NOÐźÅͨ·Ñо¿ÓñÀÉÉ¡MHBFCÄæתѹÁ¦³¬¸ººÉÐÄÊÒÖع¹µÄµ÷¿Ø»úÖÆ£¬ÏîÄ¿Åú×¼ºÅ:?**£¬ÆðÖ¹ÄêÔ£º2016.01-2019.12.£¨¸ºÔðÈË£¬ÔÚÑУ©ÏîÄ¿¶þ£º¹ú¼Ò½ÌÓý²¿»ôÓ¢¶«½ÌÓý»ù½ðÏîÄ¿£¬»ùÓÚeNOS-NOÐźÅͨ·Ñо¿ÓñÀÉÉ¡MHBFCÄæתѹÁ¦³¬¸ººÉÐÄÊÒÖع¹µÄµ÷¿Ø»úÖÆ¡£ÏîÄ¿±àºÅ:?151107£¬ÆðÖ¹ÄêÔ£º2016.03-2019.03.?£¨¸ºÔðÈË£¬ÔÚÑУ©ÏîÄ¿Èý£º¹ãÎ÷×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬ÓñÀÉÉ¡²é¶ûͪ¶ÔѹÁ¦³¬¸ººÉ´óÊóÐÄѪ¹ÜÖع¹µÄ¸ÉÔ¤×÷Óü°»úÖÆÑо¿£¬ÏîÄ¿ÈÎÎñÊé±àºÅ?2013GXNSFAA019175£¬ÆðÖ¹ÄêÔ£º2013.4?-2016.3¡££¨¸ºÔðÈË£¬ÒѽáÌ⣩ÏîÄ¿ËÄ£º¹ãÎ÷×ÔÈ»¿ÆѧÇàÄê»ù½ðÏîÄ¿£¬ÓñÀÉÉ¡¶àÌǶÔÒ»Ïß¿¹½áºËÒ©ËùÖÂÒ©ÎïÐÔ¸ÎËðÉ˵ı£»¤×÷ÓÃÑо¿£¬ÈÎÎñÊé±àºÅ£º2012GXNSFBA053094£¬ÆðÖ¹ÄêÔ£º2012.4?-2015.3¡££¨¸ºÔðÈË£¬ÒѽáÌ⣩ÏîÄ¿Î壺¹ãÎ÷ÖصãʵÑéÊÒ¿ª·¢»ù½ð¿ÎÌ⣬ÓñÀÉÉ¡²é¶ûͪ¶ÔÐļ¡È±ÑªÔÙ¹à×¢ËðÉËNF-¦ÊBÐźÅͨ·µÄµ÷¿Ø×÷Óü°»úÖÆÑо¿£¬ÏîÄ¿±àºÅ£ºFPRU2013-3£¬Æðֹʱ¼ä£º2013?-2014Ä꣨¸ºÔðÈË£¬ÒѽáÌ⣩ÏîÄ¿Áù£º¹ãÎ÷ÓÅÐ㲩ʿѧλÂÛÎÄÅàÓýÏîÄ¿£¬17-¼×Ñõ»ù-7ôÇ»ù-±½²¢ß»à«²é¶ûͪ¶ÔÐÄѪ¹ÜÖع¹µÄ¸ÉÔ¤×÷Óü°»úÖÆÑо¿£¬ÏîÄ¿±àºÅ£ºYCBZ**£¬Æðֹʱ¼ä£º2012?-2014Ä꣨¸ºÔðÈË£¬ÒѽáÌ⣩¡£